GRK2 Protein Mediates the ANRIL, a lncRNA, to Affect the Proliferation and Apoptosis of Kasumi-1 Cells.

IF 3.3 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Siqi Wang, Chengsi Zhang, Huali Hu, Jianxia Xu, Jinxin Zhang, Wu Zhou, Fahua Deng, Yaming Zhang, Chenlong Hu, Yuancheng Liu, Hai Huang, Sixi Wei
{"title":"GRK2 Protein Mediates the ANRIL, a lncRNA, to Affect the Proliferation and Apoptosis of Kasumi-1 Cells.","authors":"Siqi Wang, Chengsi Zhang, Huali Hu, Jianxia Xu, Jinxin Zhang, Wu Zhou, Fahua Deng, Yaming Zhang, Chenlong Hu, Yuancheng Liu, Hai Huang, Sixi Wei","doi":"10.31083/j.fbl2910362","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A long non-coding RNAs (LncRNAs) called antisense noncoding RNA in the INK4 locus (<i>ANRIL</i>), has emerged as substantial regulators of cell survival in acute myeloid leukemia (AML). However, its speciffc and potential mechanism is uncertain in AML. In this research, we investigated the role of <i>ANRIL</i> in cell proliferation, apoptosis, and the underlying mechanism in AML cells.</p><p><strong>Methods: </strong><i>ANRIL</i> expression was quantified by real-time quantitative polymerase chain reaction (RT-qPCR). Kasumi-1 cells were transfected with LV-<i>ANRIL</i> plasmid to upregulate <i>ANRIL</i> expression, with or without co-transfection with a G Protein-Coupled Receptor Kinase 2 (GRK2) siRNA. Additionally, these cells were transfected with sh-<i>ANRIL</i> plasmid to inhibit <i>ANRIL</i> expression, with or without co-transfection with a GRK2 overexpression plasmid. Cell proliferation and apoptosis were determined using the cell counting kit-8 (CCK8) and flow cytometry. Protein expression levels of phosphatidylinositide 3-kinases (PI3K), protein kinase B (AKT), phosphorylated-Akt (p-AKT), Bcl-2-associated protein x (BAX), B-cell leukemia/lymphoma 2 protein (BCL-2), proliferating cell nuclear antigen (PCNA), cleaved caspase-3, and GRK2 were detected by western blot. The RNA-binding protein immunoprecipitation (RIP) assay was conducted to investigate the interaction between <i>ANRIL</i> and GRK2.</p><p><strong>Results: </strong><i>ANRIL</i> expression was increased in Kasumi-1 cells. <i>ANRIL</i> upregulation expression promoted cell proliferation and inhibited apoptosis. Furthermore, its upregulation led to increased expressions of PI3K, AKT, p-AKT, PCNA, and BCL-2, and decreased expression of BAX in Kasumi-1 cells. Additionally, transfection with GRK2 siRNA attenuated the promoting effect of LV-<i>ANRIL</i> on Kasumi-1 cells proliferation and the PI3K/AKT pathway, increased BAX and cleaved caspase-3 expressions, and decreased BCL-2 and PCNA expressions. GRK2 overexpression reversed the inhibitory effect of sh-<i>ANRIL</i> on cell proliferation and the PI3K/AKT pathway. Furthermore, it promoted BCL-2 and PCNA expressions, and inhibited BAX and cleaved caspase-3 expressions. RIP assay confirmed the physical interaction between <i>ANRIL</i> and GRK2.</p><p><strong>Conclusion: </strong>The GRK2 protein-mediated <i>ANRIL</i>, increasing Kasumi-1 cell proliferation and inhibiting apoptosis by activating the PI3K/AKT/BCL-2 pathway.</p>","PeriodicalId":73069,"journal":{"name":"Frontiers in bioscience (Landmark edition)","volume":"29 10","pages":"362"},"PeriodicalIF":3.3000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in bioscience (Landmark edition)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/j.fbl2910362","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A long non-coding RNAs (LncRNAs) called antisense noncoding RNA in the INK4 locus (ANRIL), has emerged as substantial regulators of cell survival in acute myeloid leukemia (AML). However, its speciffc and potential mechanism is uncertain in AML. In this research, we investigated the role of ANRIL in cell proliferation, apoptosis, and the underlying mechanism in AML cells.

Methods: ANRIL expression was quantified by real-time quantitative polymerase chain reaction (RT-qPCR). Kasumi-1 cells were transfected with LV-ANRIL plasmid to upregulate ANRIL expression, with or without co-transfection with a G Protein-Coupled Receptor Kinase 2 (GRK2) siRNA. Additionally, these cells were transfected with sh-ANRIL plasmid to inhibit ANRIL expression, with or without co-transfection with a GRK2 overexpression plasmid. Cell proliferation and apoptosis were determined using the cell counting kit-8 (CCK8) and flow cytometry. Protein expression levels of phosphatidylinositide 3-kinases (PI3K), protein kinase B (AKT), phosphorylated-Akt (p-AKT), Bcl-2-associated protein x (BAX), B-cell leukemia/lymphoma 2 protein (BCL-2), proliferating cell nuclear antigen (PCNA), cleaved caspase-3, and GRK2 were detected by western blot. The RNA-binding protein immunoprecipitation (RIP) assay was conducted to investigate the interaction between ANRIL and GRK2.

Results: ANRIL expression was increased in Kasumi-1 cells. ANRIL upregulation expression promoted cell proliferation and inhibited apoptosis. Furthermore, its upregulation led to increased expressions of PI3K, AKT, p-AKT, PCNA, and BCL-2, and decreased expression of BAX in Kasumi-1 cells. Additionally, transfection with GRK2 siRNA attenuated the promoting effect of LV-ANRIL on Kasumi-1 cells proliferation and the PI3K/AKT pathway, increased BAX and cleaved caspase-3 expressions, and decreased BCL-2 and PCNA expressions. GRK2 overexpression reversed the inhibitory effect of sh-ANRIL on cell proliferation and the PI3K/AKT pathway. Furthermore, it promoted BCL-2 and PCNA expressions, and inhibited BAX and cleaved caspase-3 expressions. RIP assay confirmed the physical interaction between ANRIL and GRK2.

Conclusion: The GRK2 protein-mediated ANRIL, increasing Kasumi-1 cell proliferation and inhibiting apoptosis by activating the PI3K/AKT/BCL-2 pathway.

GRK2 蛋白介导 lncRNA ANRIL 影响 Kasumi-1 细胞的增殖和凋亡
背景:一种名为INK4基因座反义非编码RNA(ANRIL)的长非编码RNA(LncRNA)已成为急性髓性白血病(AML)中细胞存活的重要调节因子。然而,其在急性髓性白血病中的特异性和潜在机制尚不确定。本研究探讨了ANRIL在AML细胞增殖、凋亡中的作用及其内在机制:方法:采用实时定量聚合酶链反应(RT-qPCR)对ANRIL的表达进行定量。用 LV-ANRIL 质粒转染 Kasumi-1 细胞以上调 ANRIL 的表达,同时转染或不转染 G 蛋白偶联受体激酶 2(GRK2)siRNA。此外,用 sh-ANRIL 质粒转染这些细胞以抑制 ANRIL 的表达,同时或不同时转染 GRK2 过表达质粒。使用细胞计数试剂盒-8(CCK8)和流式细胞术测定细胞增殖和凋亡。用 Western 印迹法检测磷脂酰肌醇3-激酶(PI3K)、蛋白激酶B(AKT)、磷酸化-Akt(p-AKT)、Bcl-2相关蛋白x(BAX)、B细胞白血病/淋巴瘤2蛋白(BCL-2)、增殖细胞核抗原(PCNA)、裂解的caspase-3和GRK2的蛋白表达水平。采用 RNA 结合蛋白免疫沉淀(RIP)试验研究 ANRIL 与 GRK2 之间的相互作用:结果:ANRIL在Kasumi-1细胞中表达增加。结果:ANRIL在Kasumi-1细胞中表达增加,上调表达促进细胞增殖并抑制细胞凋亡。此外,ANRIL的上调还导致Kasumi-1细胞中PI3K、AKT、p-AKT、PCNA和BCL-2的表达增加,而BAX的表达减少。此外,转染 GRK2 siRNA 可减轻 LV-ANRIL 对 Kasumi-1 细胞增殖和 PI3K/AKT 通路的促进作用,增加 BAX 和裂解的 caspase-3 的表达,降低 BCL-2 和 PCNA 的表达。GRK2的过表达逆转了sh-ANRIL对细胞增殖和PI3K/AKT通路的抑制作用。此外,它还促进了BCL-2和PCNA的表达,抑制了BAX和裂解的caspase-3的表达。RIP实验证实了ANRIL与GRK2之间的物理相互作用:结论:GRK2蛋白介导ANRIL,通过激活PI3K/AKT/BCL-2通路增加Kasumi-1细胞增殖并抑制细胞凋亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信